Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Takeda, Reina"'
Autor:
Yamamoto K; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Goyama S; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Asada S; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; The Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan., Fujino T; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Yonezawa T; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Sato N; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Takeda R; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Tsuchiya A; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Fukuyama T; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Tanaka Y; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Yokoyama A; National Cancer Center Tsuruoka Metabolomics Laboratory, Yamagata, Japan., Toya H; RNA Biology Laboratory, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan., Kon A; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Nannya Y; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Onoguchi-Mizutani R; Isotope Science Center, The University of Tokyo, Tokyo, Japan., Nakagawa S; RNA Biology Laboratory, Faculty of Pharmaceutical Sciences, Hokkaido University, Hokkaido, Japan., Hirose T; Graduate School of Frontier Biosciences, Osaka University, Suita, Japan., Ogawa S; Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan., Akimitsu N; Isotope Science Center, The University of Tokyo, Tokyo, Japan., Kitamura T; Division of Cellular Therapy, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Electronic address: kitamura@ims.u-tokyo.ac.jp.
Publikováno v:
Cell reports [Cell Rep] 2021 Aug 24; Vol. 36 (8), pp. 109576.
Autor:
Fujino T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Goyama S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Sugiura Y; Department of Biochemistry, Keio University School of Medicine, and Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology (ERATO), Suematsu Gas Biology Project, Shinjuku-ku, Tokyo, Japan., Inoue D; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, USA.; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe City, Hyogo, Japan., Asada S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan., Yamasaki S; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Matsumoto A; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Yamaguchi K; Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Isobe Y; Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Tsuchiya A; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Shikata S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Sato N; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Morinaga H; Department of Stem Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan., Fukuyama T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Tanaka Y; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Fukushima T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Takeda R; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Yamamoto K; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Honda H; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan., Nishimura EK; Department of Stem Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan., Furukawa Y; Division of Clinical Genome Research, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Shibata T; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan., Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, USA., Suematsu M; Department of Biochemistry, Keio University School of Medicine, and Japan Science and Technology Agency (JST), Exploratory Research for Advanced Technology (ERATO), Suematsu Gas Biology Project, Shinjuku-ku, Tokyo, Japan., Kitamura T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan. kitamura@ims.u-tokyo.ac.jp.
Publikováno v:
Nature communications [Nat Commun] 2021 Mar 23; Vol. 12 (1), pp. 1826. Date of Electronic Publication: 2021 Mar 23.
Autor:
Takeda R; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Asada S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; The Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan., Park SJ; Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Yokoyama A; National Cancer Center Tsuruoka Metabolomics Laboratory, Yamagata, Japan., Becker HJ; Division of Stem Cell Biology, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kanai A; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and., Hershberger C; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH., Hayashi Y; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan., Yonezawa T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Tamura M; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Fukushima T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Tanaka Y; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Fukuyama T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Matsumoto A; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; and., Yamasaki S; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; and., Nakai K; Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Yamazaki S; Division of Stem Cell Biology, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Stem Cell Therapy, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan., Inaba T; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Shibata T; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; and., Inoue D; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan., Honda H; The Institute of Laboratory Animals, Tokyo Women's Medical University, Tokyo, Japan., Goyama S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, and., Kitamura T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
Publikováno v:
Blood [Blood] 2020 Oct 01; Vol. 136 (14), pp. 1670-1684.
Autor:
Asada S; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Goyama S; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Inoue D; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA., Shikata S; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Takeda R; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Fukushima T; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Yonezawa T; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Fujino T; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Hayashi Y; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Kawabata KC; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan.; Department of Hematology/Oncology, Weill Cornell Medical College, New York, NY, 10021, USA., Fukuyama T; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Tanaka Y; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Yokoyama A; National Cancer Center Tsuruoka Metabolomics Laboratory, Yamagata, 9970052, Japan., Yamazaki S; Division of Stem Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Kozuka-Hata H; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Oyama M; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan., Kojima S; Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, 1130033, Japan., Kawazu M; Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, 1130033, Japan., Mano H; Department of Cellular Signaling, Graduate School of Medicine, The University of Tokyo, Tokyo, 1130033, Japan.; National Cancer Center Research Institute, Tokyo, 1040045, Japan., Kitamura T; Division of Cellular Therapy, Advanced Clinical Research Center, and Division of Stem Cell Signaling, Center for Stem Cell Biology and Regenerative Medicine, Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan. kitamura@ims.u-tokyo.ac.jp.
Publikováno v:
Nature communications [Nat Commun] 2018 Jul 16; Vol. 9 (1), pp. 2733. Date of Electronic Publication: 2018 Jul 16.
Autor:
Nagase R; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Inoue D; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan inoued@mskcc.org.; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY., Pastore A; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY., Fujino T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Hou HA; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Yamasaki N; Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Goyama S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Saika M; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kanai A; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Sera Y; Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan., Horikawa S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Ota Y; Department of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Asada S; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Hayashi Y; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kawabata KC; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Takeda R; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Tien HF; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan., Honda H; Department of Disease Model, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women's Medical University, Tokyo, Japan., Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY., Kitamura T; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan kitamura@ims.u-tokyo.ac.jp.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2018 Jun 04; Vol. 215 (6), pp. 1729-1747. Date of Electronic Publication: 2018 Apr 11.